Growth hormone (somatropin) is a Class C controlled drug under the Misuse of Drugs Act 1971 and is listed in Schedule 4 Part II of the Misuse of Drugs Regulations 2001
The science behind Setria 21
No harmful bleaching agents or unregulated substances
In the current Poisons List, Schedule 2 has a variation to the entry for codeine when compounded in preparations containing 10mg or less of codeine, where the restriction on a primary pack containing 25 dosage units or less in the SUSDP has been removed
It explains how inhibiting GDF-8 Myostatin can enhance muscle mass, strength, recovery, and bone density while aiding in conditions like muscular dystrophy and sarcopenia
In total joint arthroplasty, where wound complications and periprosthetic joint infection carry substantial consequences, perioperative risk minimization should remain the priority